Despite trading at 30x forward earnings, Celestica's strong growth, diversified customer base, and increasing high-margin IP ...

Celestica Inc. (NYSE:CLS – Get Free Report) (TSE:CLS) shares were up 1.7% during mid-day trading on Thursday after Barclays raised their price target on the stock from $139.00 to $157.00. Barclays ...

Choreo LLC bought a new stake in Celestica Inc. (NYSE:CLS – Free Report) (TSE:CLS) in the 4th quarter, HoldingsChannel ...

Barclays raised the firm’s price target on Celestica (CLS) to $157 from $139 and keeps an Overweight rating on the shares after meeting with ...

Investors have fallen in love with Celestica because its profits have surged, jumping to $426-million in fiscal 2024, from ...

Given their solid financials and healthy growth prospects, these two Canadian stocks could be excellent buys. The post Top ...

In a report released today, George Wang CFA from Barclays maintained a Buy rating on Celestica (CLS – Research Report), with a price target of ...

Brinker International, Business First Bancshares, AZEK, Celestica and Boston Scientific have been highlighted in this Screen ...

Its high growth potential, resilience to the emergence of low-cost LLMs, and low valuation make it a compelling stock in the ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $130.0 and $180.0 for Celestica, spanning the last three months.

What Happened: According to a Form 4 filing with the U.S. Securities and Exchange Commission on Monday, Cooper sold 65,000 shares of Celestica. The total transaction value is $8,435,793. Celestica 's ...